Koninklijke Philips N.V.

October 29, 2026 New CE-marked solution leverages the industry-leading Philips Azurion platform to integrate CT-derived insights and treatment planning directly into the procedural workflow, helping physicians make informed decisions during treatment. Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and a pioneer in image-guided therapy, today announced the launch of Philips UniGuide 3D Live Guidance in Europe and other CE-marked markets.

Leading beauty industry voices, Dr. Aamna Adel, UK Consultant Dermatologist and HCP influencer , Alice Crossley, Principal Strategic Foresight Analyst at The Future Laboratory , and Tiffany Buathier, Founder of The New Well,  share their perspectives on the next phase of beauty technology and what it means for the industry. AMSTERDAM, Oct. 27, 2026 /PRNewswire/ -- Personal care has become a meaningful part of daily well-being, with people making intentional choices about how they begin their mornings, unwind in the evening and care for themselves throughout the day.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) – From character creation and custom skins to real-world cosplay fashion and streaming culture, gaming has its own visual language, and its influence on personal style extends beyond the screen. For many male gamers, the characters they play are another source of inspiration for how they show up IRL. New research from Philips Norelco OneBlade finds that 80% of U.S. male gamers ages 18–45 have taken inspiration from gaming a.

October 20, 2026 Advanced reporting and workflow capabilities developed by MediReport are expected to complement Philips' cardiovascular informatics portfolio and support its evolution toward a more connected, AI-enabled and cloud-ready cardiovascular experience.  Amsterdam, the Netherlands – October 20, 2026 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how advanced reporting and workflow capabilities developed by MediReport are expected to complement its cardiovascular informatics portfolio and support its broader Integrated Diagnostics vision ahead of Transcatheter Cardiovascular Therapeutics (TCT) 2026.